These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12821834)

  • 21. Antifungal prophylaxis in solid organ transplant recipients.
    Brizendine KD; Vishin S; Baddley JW
    Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing fungal infections in the intensive care unit.
    De Pauw BE
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal prophylaxis in neutropenic patients with hematologic malignancies: is there a real benefit?
    Böhme A; Karthaus M; Hoelzer D
    Chemotherapy; 1999; 45(3):224-32. PubMed ID: 10224346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing epidemiology of invasive fungal infections: new threats.
    Maschmeyer G
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of fungal infection in transplantation.
    Paya CV
    Transpl Infect Dis; 2002; 4 Suppl 3():46-51. PubMed ID: 12486792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prophylaxis and treatment for invasive fungal infections in solid organ transplant recipients].
    Mitsutake K
    Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):167-9. PubMed ID: 16940950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal prophylaxis in bone marrow transplantation.
    Milliken ST; Powles RL
    Rev Infect Dis; 1990; 12 Suppl 3():S374-9. PubMed ID: 2184515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis of invasive mycoses in solid organ transplantation.
    Radack KP; Alexander BD
    Curr Infect Dis Rep; 2009 Nov; 11(6):427-34. PubMed ID: 19857381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changing face of epidemiology of invasive fungal disease in Europe.
    Lass-Flörl C
    Mycoses; 2009 May; 52(3):197-205. PubMed ID: 19391253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of invasive fungal infection.
    Castón-Osorio JJ; Rivero A; Torre-Cisneros J
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S103-9. PubMed ID: 19013332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of opportunistic invasive mycoses.
    Kullberg BJ; Oude Lashof AM
    Eur J Med Res; 2002 May; 7(5):183-91. PubMed ID: 12069910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fungal infections after lung transplantation.
    Solé A; Salavert M
    Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.
    Patterson JE; Peters J; Calhoon JH; Levine S; Anzueto A; Al-Abdely H; Sanchez R; Patterson TF; Rech M; Jorgensen JH; Rinaldi MG; Sako E; Johnson S; Speeg V; Halff GA; Trinkle JK
    Transpl Infect Dis; 2000 Mar; 2(1):22-8. PubMed ID: 11429006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fungal infections in solid organ transplant recipients.
    Hadley S; Karchmer AW
    Infect Dis Clin North Am; 1995 Dec; 9(4):1045-74. PubMed ID: 8747778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive fungal infections and antifungal therapies in solid organ transplant recipients.
    Gabardi S; Kubiak DW; Chandraker AK; Tullius SG
    Transpl Int; 2007 Dec; 20(12):993-1015. PubMed ID: 17617181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD; Ghent C; Grant D; Horbay GL; McDougal J; David Colby W
    Transplantation; 2003 Sep; 76(6):977-83. PubMed ID: 14508365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylaxis against fungal infections in solid organ and hematopoietic stem cells transplantation].
    Rabagliati R; Santolaya ME
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S11-8. PubMed ID: 23282550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.